Mavenclad Will Be Another Oral Option to Help Treat Multiple Sclerosis

You'll start hearing about a new oral med, Mavenclad (MAY-ven-clad, cladribine) for treating multiple sclerosis (MS).

It helps decrease the frequency of multiple sclerosis "flare-ups"...and helps delay progression of disability.

But expect Mavenclad to be saved for patients who cannot tolerate or who have had a relapse while on other MS treatments.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote